HCA Healthcare Inc. (HCA)
Company Description
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States.
The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities.
In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services.
As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England.
The company was formerly known as HCA Holdings, Inc.
HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Country | United States |
IPO Date | Mar 10, 2011 |
Industry | Medical - Care Facilities |
Sector | Healthcare |
Employees | 226,000 |
CEO | Samuel N. Hazen |
Contact Details
Address: One Park Plaza Nashville, Tennessee United States | |
Website | https://www.hcahealthcare.com |
Stock Details
Ticker Symbol | HCA |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000860730 |
CUSIP Number | 40412C101 |
ISIN Number | US40412C1018 |
Employer ID | 27-3865930 |
SIC Code | 8062 |
Key Executives
Name | Position |
---|---|
Samuel N. Hazen | Chief Executive Officer & Director |
Chad J. Wasserman | Senior Vice President & Chief Information Officer |
Jon Mack Foster | Executive Vice President & Chief Operating Officer |
Michael A. Marks | Chief Financial Officer & Executive Vice President |
Christopher F. Wyatt | Senior Vice President, Principal Accounting Officer & Controller |
Dr. Michael S. Cuffe M.B.A., M.D. | Executive Vice President & Chief Clinical Officer |
Dr. Thomas F. Frist Jr., M.D. | Founder & Chairman Emeritus |
Frank George Morgan C.F.A. | Vice President of Investor Relations |
Michael R. McAlevey | Executive Vice President and Chief Legal & Administrative Officer |
Wendy Warren | Senior Vice President, Chief Ethics & Compliance Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 28, 2025 | 4 | Filing |
Mar 14, 2025 | ARS | Filing |
Mar 14, 2025 | DEFA14A | Filing |
Mar 14, 2025 | DEF 14A | Filing |
Mar 04, 2025 | PRE 14A | Filing |
Feb 24, 2025 | 8-K | Current Report |
Feb 21, 2025 | 8-K | Current Report |
Feb 20, 2025 | 8-K | Current Report |
Feb 20, 2025 | 424B5 | Filing |
Feb 19, 2025 | FWP | Filing |